Effect of intravitreal aflibercept on recalcitrant diabetic macular edema

BACKGROUND: Despite anti-VEGF therapy, some patients develop chronic diabetic macular edema. The objective of this study was to evaluate anatomic and visual outcomes of switching patients with chronic DME from intravitreal bevacizumab or ranibizumab to intravitreal aflibercept injection. METHODS: In...

Descripción completa

Detalles Bibliográficos
Autores principales: Klein, Kendra A., Cleary, Tina S., Reichel, Elias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376679/
https://www.ncbi.nlm.nih.gov/pubmed/28373914
http://dx.doi.org/10.1186/s40942-017-0064-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5376679/
https://www.ncbi.nlm.nih.gov/pubmed/28373914
http://dx.doi.org/10.1186/s40942-017-0064-0

Ejemplares similares